Nanotechnology in Targeting Neurodegenerative Diseases
Keywords:
nanotechnology, neurodegeneration, therapy, brain, diseaseAbstract
Nanotechnology presents a frontier in the treatment of neurodegenerative diseases, offering precise drug delivery systems that can cross the blood-brain barrier. This review delves into the nanocarriers designed to enhance the bioavailability and efficacy of therapeutic agents for conditions such as Alzheimer's and Parkinson's disease. By examining recent advancements and challenges in the field, we aim to elucidate the potential of nanotechnology in revolutionizing treatments for debilitating neurodegenerative disorders.
This is a free preview. The complete article is available with a valid subscription.
References
РІЗАК, Г. ВПЛИВ РІЗНИХ МЕТОДІВ СИНТЕЗУ НА ТОКСИЧНІСТЬ ТА ЕФЕКТИВНІСТЬ НОВИХ БІОЛОГІЧНО АКТИВНИХ СПОЛУК НА ОСНОВІ ТІЄНОПІРИМІДИНІВ. ПРОБЛЕМИ ХІМІЇ ТА СТАЛОГО РОЗВИТКУ Учредители: Publishing House Helvetica (Publications), (4), 15-24.
Sharma, V. K., Marla, S., Zheng, W., Mishra, D., Huang, J., Zhang, W., ... & Cook, D. E. (2022). CRISPR guides induce gene silencing in plants in the absence of Cas. Genome Biology, 23(1), 6.
